# Heor服务市场

> HEOR服务市场研究报告按服务类型（HEOR研究与咨询、市场准入与报销、医学传播、健康经济学与结果研究（HEOR））、按应用（肿瘤学、免疫学、罕见病、心血管疾病）、按最终用户（制药和生物技术公司、医疗服务提供者、政府机构、研究组织）以及按地区（北美、欧洲、南美、亚太、中东和非洲）- 预测到2035年

- **Forecast Period:** 2025 - 2035
- **CAGR:** 5.69%
- **2024:** $ 28.86 Billion
- **2025:** $ 30.5 Billion
- **2035:** $ 53.05 Billion
- **Key Players:** IQVIA (US), Optum (US), McKesson(US), Cerner (US), PAREXEL (US), Covance (US), Market Research Future Health (GB), Analysis Group (US), Evidera (US), Truist Securities (US)

**Report ID:** MRFR/HC/27628-HCR · **Pages:** 128 · **Author:** Rahul Gotadki · **Last Updated:** May 03, 2026

**URL:** https://www.marketresearchfuture.com/reports/heor-service-market-29343

---

## Market Summary

## **HEOR Service Market Overview**

As per MRFR analysis, the Heor Service Market Size was estimated at 28.86 (USD Billion) in 2024. The Heor Service Market Industry is expected to grow from 30.50 (USD Billion) in 2025 to 50.19 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 5.69% during the forecast period (2025 - 2034).

### **Key HEOR Service Market Trends Highlighted**

Key market drivers for the HEOR Service Market include the increasing demand for value-based healthcare, the rising prevalence of chronic diseases, and the growing adoption of personalized medicine.

Opportunities in the HEOR Service Market lie in the expansion of digital health technologies, partnerships with pharmaceutical companies, and the development of innovative HEOR solutions.

Recent trends in the HEOR Service Market include the integration of artificial intelligence and machine learning, the use of real-world data, and the focus on patient-centered outcomes.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **HEOR Service Market Drivers**

Rising Demand for Value-Based Healthcare

The increasing focus on value-based healthcare is a major driver of growth in the Global HEOR Service Market Industry. As healthcare providers and payers seek to optimize outcomes and reduce costs, they are increasingly turning to HEOR services to demonstrate the value of their products and services.

HEOR services can help companies develop and implement value-based pricing strategies, conduct cost-effectiveness analyses, and measure the impact of their products on patient outcomes.

By providing evidence of the value of their products, companies can increase their chances of reimbursement and market share. The rising demand for value-based healthcare is being driven by a number of factors, including the increasing prevalence of chronic diseases, the rising cost of healthcare, and the growing number of value-based payment models.

As a result, the demand for HEOR services is expected to continue to grow in the coming years. Here are some specific examples of how HEOR services are being used to support value-based healthcare: Developing and implementing value-based pricing strategies: HEOR services can help companies develop value-based pricing strategies that are aligned with the value that their products provide to patients.

This can involve conducting market research to understand the value that patients place on different attributes of a product, and developing pricing models that reflect this value.

Conducting cost-effectiveness analyses: HEOR services can help companies conduct cost-effectiveness analyses to assess the value of their products compared to other treatment options. This can involve estimating the costs and benefits of a product over its lifetime and comparing these costs and benefits to those of other products.

Measuring the impact of products on patient outcomes: HEOR services can help companies to measure the impact of their products on patient outcomes. This can involve conducting clinical trials to assess the efficacy and safety of a product and collecting data on patient outcomes in real-world settings.

Technological Advancements

The Global HEOR Service Market Industry is also being driven by technological advancements. The development of new technologies, such as big data analytics and artificial intelligence (AI), is making it possible to collect and analyze large amounts of data on patient outcomes. This data can be used to develop more accurate and personalized HEOR analyses.

Increasing Regulatory Requirements

The increasing regulatory requirements for HEOR services is another factor driving growth in the Global HEOR Service Market Industry. In many countries, healthcare providers and payers are required to demonstrate the value of their products and services before they can be reimbursed. This has led to an increased demand for HEOR services as companies seek to comply with these requirements.

## **HEOR Service Market Segment Insights**

### **HEOR Service Market Service Type Insights**

The Global HEOR Service Market is segmented by Service Type into HEOR Research and Consulting, Market Access and Reimbursement, Medical Communications, and Health Economics and Outcomes Research (HEOR).

Among these segments, HEOR Research and Consulting held the largest market share in 2023 and is projected to maintain its dominance throughout the forecast period. The growth of this segment can be attributed to the increasing demand for HEOR studies to support drug development and regulatory submissions.

Market Access and Reimbursement is another significant segment, driven by the rising need for assistance in navigating complex reimbursement landscapes.

Medical Communications is also gaining traction as companies seek to effectively communicate the value of their products to healthcare professionals and patients.

Health Economics and Outcomes Research (HEOR) is expected to witness steady growth due to its importance in assessing the cost-effectiveness and value of healthcare interventions.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **HEOR Service Market Application Insights**

Application Segment Insight and Overview The application segment of the Global HEOR Service Market offers diverse opportunities and challenges. Oncology, immunology, rare diseases, and cardiovascular disease represent key therapeutic areas driving market growth.

Oncology emerged as the largest application segment, accounting for a significant share of the Global HEOR Service Market revenue in 2023. The increasing prevalence of cancer and the development of novel oncology therapies fuel this segment's growth.

Immunology is another rapidly expanding application segment driven by the rising prevalence of immune-mediated diseases and the advancements in immunotherapy.

The segment is anticipated to witness substantial growth over the forecast period. Rare Disease presents a niche but growing market segment. The increasing recognition of rare diseases and the development of targeted therapies for these conditions drive segment growth.

Cardiovascular Disease remains a major application area, with the increasing incidence of heart conditions and the need for effective patient management. The segment is expected to contribute significantly to the Global HEOR Service Market growth in the coming years.

Overall, the application segment of the Global HEOR Service Market exhibits a promising outlook, with Oncology,

[Immunology](../../../reports/immunology-market-30261)

, Rare Disease, and cardiovascular disease serving as key growth drivers.

### **HEOR Service Market End-User Insights**

The Global HEOR Service Market segmentation by End-User includes Pharmaceutical and Biotechnology Companies, Healthcare Providers, Government Agencies, and Research Organizations. Pharmaceutical and Biotechnology companies accounted for the largest share of the market in 2023, owing to the increasing need for HEOR studies to support drug development and commercialization.

Healthcare providers are expected to witness significant growth, driven by the rising adoption of HEOR to improve patient outcomes and reduce healthcare costs.

Government agencies are also expected to contribute to the market growth due to the growing emphasis on healthcare cost-effectiveness and value-based pricing.

Research organizations are anticipated to play a crucial role in conducting HEOR studies and providing insights to support decision-making in the healthcare industry.

### **HEOR Service Market Regional Insights**

The Global HEOR Service Market is expected to witness significant growth in the coming years. Regionally, North America held the largest market share in 2023, with a valuation of 10.5 billion USD. Europe is expected to follow with a market size of 7.2 billion USD, while APAC is projected to grow at the highest CAGR of 7.1% during the forecast period 2025-2034

South America and MEA contributed to the overall market growth, with market sizes of 3.2 billion USD and 2.9 billion USD, respectively, in 2023.

The increasing adoption of HEOR services by pharmaceutical and biotechnology companies, along with growing government support for healthcare research and development, is driving the market growth.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **HEOR Service Market Key Players and Competitive Insights**

Major players in the HEOR Service Market industry are constantly striving to stay ahead of the competition by investing in research and development, expanding their service offerings, and forming strategic partnerships. Leading HEOR Service Market players are focusing on providing innovative solutions that cater to the evolving needs of clients in the pharmaceutical and biotechnology industries.

The HEOR Service Market development is driven by the increasing demand for evidence-based decision-making in healthcare, the growing complexity of clinical trials, and the need for efficient and effective communication of health outcomes.

IQVIA is a leading provider of HEOR Service Market services globally. The company offers a comprehensive suite of solutions that cover the entire drug development lifecycle, from early-stage research to post-marketing surveillance.

IQVIA has a strong track record of success in delivering high-quality HEOR Service Market services to clients in the pharmaceutical and biotechnology industries. The company's team of experts has deep knowledge and experience in the field of HEOR Service Market and they are committed to providing innovative solutions that meet the evolving needs of clients.

 Another major player in the HEOR Service Market industry is Evidera. The company offers a range of HEOR Service Market services, including clinical trial design and analysis, health economics and outcomes research, and market access and reimbursement support.

Evidera has a strong reputation for providing high-quality HEOR Service Market services to clients in the pharmaceutical and biotechnology industries. The company's team of experts has deep knowledge and experience in the field of the HEOR Service Market, and they are committed to providing innovative solutions that meet the evolving needs of clients.

**Key Companies in the HEOR Service Market Include**

## **HEOR Service Market Industry Developments**

The growth is attributed to factors such as the increasing adoption of value-based healthcare, the rising prevalence of chronic diseases, and the growing demand for personalized medicine. Key industry participants are focusing on strategic collaborations, acquisitions, and partnerships to expand their service offerings and gain a competitive edge in the market.

Recent developments include the acquisition of Health Economics and Outcomes Research firm Precision Health Economics by Evidera in 2023 and the partnership between IQVIA and Aetion in 2022 to enhance real-world evidence-generation capabilities.

The market is expected to witness continued growth in the coming years, driven by advancements in technology, increasing government support for HEOR, and the growing adoption of digital health solutions.

## **HEOR Service Market Segmentation Insights**

### **HEOR Service Market Service Type Outlook**

### **HEOR Service Market Application Outlook**

### **HEOR Service Market End-User Outlook**

### **HEOR Service Market Regional Outlook**

## Market Drivers

### 先进技术的整合

HEOR服务市场正在经历显著的转变，这得益于人工智能和机器学习等先进技术的整合。这些技术促进了对大量数据集的分析，使得健康经济评估更加准确。例如，人工智能算法可以预测患者的结果和治疗成本，从而增强医疗提供者的决策过程。预计到2025年，医疗保健领域的人工智能市场将达到约360亿美元，显示出强劲的增长轨迹。这一技术进步不仅简化了操作，还提高了生成证据的质量，从而影响政策决策和报销策略。因此，HEOR服务市场的利益相关者正越来越多地采用这些技术，以保持竞争力并满足医疗系统不断变化的需求。

### 监管变更与合规

HEOR服务市场受到不断变化的监管框架的显著影响，这些框架要求严格的健康经济评估。监管机构越来越要求在新疗法获得市场准入之前提供成本效益和预算影响分析的证据。这一趋势在医疗成本受到审查的地区尤为明显，促使利益相关者投资HEOR服务以确保合规。例如，最近在多个司法管辖区的法规要求制药公司在提交临床数据的同时，提供全面的经济评估。这一转变突显了HEOR服务在应对复杂监管环境中的重要性，因为它们提供了支持市场准入和报销谈判所需的证据。因此，利用HEOR服务的组织在满足监管要求和增强市场存在感方面处于更有利的位置。

### 关注基于价值的护理

HEOR服务市场正日益与以价值为基础的医疗原则相一致，这强调了患者结果与成本的关系。这一范式转变是由医疗支付方和提供者推动的，他们寻求优化资源配置，同时确保高质量的护理。根据最近的数据，约70%的医疗机构正在向以价值为基础的护理模式转型。这一趋势需要强有力的健康经济评估，以证明治疗和干预措施的成本效益。因此，HEOR服务对于希望在这一复杂环境中导航的组织变得不可或缺。通过提供支持医疗干预经济价值的证据，HEOR服务在影响报销决策和政策制定方面发挥着关键作用，从而塑造医疗服务的未来。

### 对真实世界证据的需求上升

HEOR服务市场正在见证对真实世界证据（RWE）需求的激增，因为利益相关者希望了解干预措施在日常临床环境中的有效性。RWE提供的见解通常在传统临床试验中缺失，从而提供了对治疗结果的更全面的视角。最近的研究表明，超过60%的制药公司正在利用RWE来指导其产品开发和市场准入策略。这种对RWE日益依赖正在重塑健康经济学和结果研究的格局，因为它允许对医疗干预措施进行更细致的评估。因此，专注于生成和分析RWE的HEOR服务对于希望在真实世界场景中展示其产品价值的组织变得越来越重要。

### 更加关注以患者为中心的方法

HEOR服务市场越来越重视以患者为中心的方法，反映了个性化医疗的更广泛趋势。这一转变强调了在健康经济评估中理解患者偏好、经历和结果的重要性。最近的调查显示，近80%的医疗保健利益相关者认为，纳入患者报告的结果对于有效决策至关重要。因此，HEOR服务正在调整以包括捕捉这些患者视角的方法，从而增强其发现的相关性和适用性。这种对以患者为中心的关注不仅提高了健康经济评估的质量，还与对医疗保健透明度和问责制日益增长的需求相一致。通过将患者见解融入评估中，HEOR服务能够更好地为政策决策提供信息并改善医疗服务。

## Future Outlook

HEOR服务市场预计将在2024年至2035年间以5.69%的年复合增长率增长，推动因素是对基于价值的医疗保健和先进分析的需求增加。

**New opportunities:**

- 基于人工智能的健康经济模型开发 真实世界证据生成服务的扩展 在HEOR战略中整合数字健康解决方案

到2035年，HEOR服务市场预计将强劲增长，反映出显著的增长和创新。

## Segment Insights

### 按服务类型：HEOR研究与咨询（最大）与市场准入和报销（增长最快）

HEOR服务市场展示了多样化的产品，HEOR研究和咨询因其在指导医疗决策中的关键作用而占据最大份额。该细分市场强调强大的数据分析和专家咨询，确保制药公司和医疗服务提供者的战略与不断变化的市场动态保持一致。相比之下，市场准入和报销正在获得关注，受到对有效策略日益增长的需求的推动，这些策略确保产品的可及性和报销，突显其作为未来增长关键参与者的实力。

HEOR研究与咨询（主导）与医学传播（新兴）

HEOR研究与咨询被公认为HEOR服务市场的主导力量，提供针对行业需求的必要分析和战略建议。这个细分市场至关重要，支持制药和医疗保健公司应对复杂的监管要求，并优化产品在市场上的定位。另一方面，医学传播代表了一个新兴细分市场，专注于科学数据的传播、证据生成和利益相关者的参与。这个领域正在迅速扩展，受到对有效沟通策略日益增长的需求的推动，尤其是在一个竞争加剧和患者群体寻求健康相关决策清晰度的环境中。

### 按应用：肿瘤学（最大）与免疫学（增长最快）

在HEOR服务市场中，肿瘤学占据了最大的市场份额，这得益于癌症发病率的增加和对强有力的医疗结果的需求。该细分市场的主导地位得到了对个性化医疗和靶向疗法日益关注的支持，使其成为健康经济评估的关键领域。相比之下，[免疫学](/zh-cn/reports/immunology-market-30261)正迅速成为增长最快的细分市场，这得益于生物制药的进步和自身免疫性疾病的激增。这一增长反映了对免疫疾病的高度关注和认识，推动了研究和服务需求的前进。

肿瘤学：主导 vs. 免疫学：新兴

肿瘤学是HEOR服务市场的主导领域，因其建立的基础设施和广泛的癌症治疗与管理研究计划而得以发展。该领域受益于治疗方法的持续创新以及对癌症护理结果的日益关注。相反，免疫学虽然目前作为一个新兴领域受到关注，但正在迅速获得关注。该领域的特点是新型生物制剂和单克隆抗体，这些正在改变自身免疫疾病的治疗范式。其增长得益于关键临床试验和对免疫介导疾病的不断理解，使其成为HEOR服务的一个关键关注领域。

### 按最终用户：制药和生物技术公司（最大）与医疗服务提供者（增长最快）

在HEOR服务市场中，终端用户之间的市场份额分布显示出制药和生物技术公司对需求的显著集中。该细分市场仍然是最大的终端用户，主要是由于对全面经济评估的需求，以支持药物开发和报销策略。医疗服务提供者紧随其后，作为一个关键细分市场，推动HEOR服务的整体需求，因为他们寻求在确保患者获得有效治疗的同时优化成本。

制药和生物技术公司（主导）与医疗服务提供者（新兴）

制药和生物技术公司主导HEOR服务市场，利用健康经济学和结果研究来指导药物开发和市场准入的决策。他们对HEOR服务的依赖源于向支付方和监管机构展示价值和有效性的必要性。同时，医疗服务提供者作为新兴参与者，越来越认识到HEOR在优化预算和提升护理服务中的重要性。他们面临着用数据驱动的证据来证明临床决策的压力，因此转向HEOR服务，以将临床结果与成本效益对齐，促进其向更具经济意识的实体转变。

## Regional Market Share Analysis

全球HEOR服务市场预计在未来几年将见证显著增长。从区域来看，北美在2023年占据了最大的市场份额，估值为105亿美元。欧洲预计将紧随其后，市场规模为72亿美元，而亚太地区预计在2025-2034年的预测期内以7.1%的最高复合年增长率增长。

南美和中东及非洲对整体市场增长做出了贡献，2023年的市场规模分别为32亿美元和29亿美元。

制药和生物技术公司对HEOR服务的日益采用，以及政府对医疗研究和开发的支持不断增加，推动了市场的增长。

## Competitive Benchmarking

HEOR服务市场目前的特点是动态竞争格局，受到对基于证据的医疗解决方案日益增长的需求和对成本效益治疗选择的需求的推动。IQVIA（美国）、Optum（美国）和PAREXEL（美国）等主要参与者在战略上定位，以利用其广泛的数据分析能力和医疗专业知识。这些公司专注于创新和数字化转型，以增强其服务产品，从而塑造一个强调数据驱动决策和以患者为中心的方法的竞争环境。

在商业策略方面，公司越来越多地本地化其服务，以更好地满足区域医疗需求，优化其供应链以提高效率。市场似乎适度分散，多个参与者争夺市场份额，但像McKesson（美国）和Covance（美国）等主要公司的集体影响力是显著的。他们的运营策略通常涉及合作伙伴关系和合作，以增强其服务能力和市场覆盖。

在2025年8月，IQVIA（美国）宣布与一家领先的制药公司建立战略合作伙伴关系，开发旨在改善患者结果的先进分析工具。这一合作可能通过将真实世界证据整合到临床决策中来增强IQVIA在市场中的地位，从而加强其在HEOR服务创新方面的承诺。这一合作的影响可能超越即时的财务收益，可能为行业内的证据生成设定新的标准。

在2025年9月，Optum（美国）推出了一个新的数字平台，旨在简化健康经济学和结果研究与临床工作流程的整合。这一举措反映了Optum对数字化转型的关注，以及其为医疗提供者提供可操作见解的目标。通过增强HEOR数据的可获取性，Optum可能会加强其竞争优势，定位自己为技术与医疗分析整合的领导者。

在2025年7月，PAREXEL（美国）通过收购一家欧洲地区HEOR咨询公司扩大了其全球足迹。这一收购表明PAREXEL增强其服务产品和扩大市场存在的战略。通过将地方专业知识与其全球能力相结合，PAREXEL可能会改善其竞争定位，更好地服务于多样化市场中的客户。

截至2025年10月，HEOR服务市场正在见证数字化程度提高、人工智能整合和对可持续性日益重视等趋势。主要参与者之间的战略联盟正在塑造竞争格局，促进创新与合作。展望未来，竞争差异化似乎将越来越依赖于技术进步和供应链的可靠性，而不仅仅是价格。这一转变表明公司在竞争方式上的潜在演变，更多地关注提供满足医疗生态系统复杂需求的创新解决方案。

## Recent News & Developments

这一增长归因于多个因素，例如基于价值的医疗保健的日益普及、慢性疾病的发病率上升以及对个性化医疗的需求不断增长。主要行业参与者正专注于战略合作、收购和伙伴关系，以扩展其服务产品并在市场中获得竞争优势。

最近的发展包括2023年Evidera收购健康经济学和结果研究公司Precision Health Economics，以及2022年IQVIA与Aetion之间的合作，以增强真实世界证据生成能力。

预计市场在未来几年将继续增长，推动因素包括技术进步、政府对HEOR的支持增加以及数字健康解决方案的日益普及。

## Report Scope

| 2024年市场规模 | 288.6（十亿美元） |
| --- | --- |
| 2025年市场规模 | 305（十亿美元） |
| 2035年市场规模 | 530.5（十亿美元） |
| 年复合增长率（CAGR） | 5.69%（2024 - 2035） |
| 报告覆盖范围 | 收入预测、竞争格局、增长因素和趋势 |
| 基准年 | 2024 |
| 市场预测期 | 2025 - 2035 |
| 历史数据 | 2019 - 2024 |
| 市场预测单位 | 十亿美元 |
| 主要公司简介 | 市场分析进行中 |
| 覆盖的细分市场 | 市场细分分析进行中 |
| 主要市场机会 | 在HEOR服务市场中整合先进的分析和人工智能，增强决策能力和价值展示。 |
| 主要市场动态 | 由于监管变化和技术进步，健康经济学和结果研究服务的需求不断上升。 |
| 覆盖的国家 | 北美、欧洲、亚太、南美、中东和非洲 |

## Frequently Asked Questions

**Q: 到2035年，HEOR服务市场的预计市场估值是多少？**
A: HEOR服务市场预计到2035年将达到530.5亿美元的估值。

**Q: 2024年HEOR服务市场的市场估值是多少？**
A: 2024年，HEOR服务市场的价值为288.6亿美元。

**Q: 2025年至2035年HEOR服务市场的预期CAGR是多少？**
A: 在2025年至2035年的预测期内，HEOR服务市场的预期CAGR为5.69%。

**Q: 在HEOR服务市场中，哪些公司被视为关键参与者？**
A: HEOR服务市场的主要参与者包括IQVIA、Optum、McKesson、Cerner和PAREXEL。

**Q: HEOR服务市场主要的服务类型有哪些？**
A: 主要服务类型包括HEOR研究与咨询、市场准入与报销以及医学传播。

**Q: 到2035年，HEOR研究和咨询部门预计将增长多少？**
A: HEOR研究与咨询部门预计将从2024年的80亿美元增长到2035年的150亿美元。

**Q: 到2035年，市场准入和报销领域的预计增长是多少？**
A: 市场准入和报销部门预计将从2024年的100亿美元增加到2035年的180亿美元。

**Q: 哪些应用领域正在推动HEOR服务市场的增长？**
A: 推动增长的应用领域包括肿瘤学、免疫学、罕见病和心血管疾病。

**Q: 到2035年，心血管疾病应用的预期市场规模是多少？**
A: 心血管疾病应用的市场规模预计将从2024年的78.6亿美元增长到2035年的160.5亿美元。

**Q: HEOR服务的主要最终用户是谁？**
A: HEOR服务的主要最终用户包括制药和生物技术公司、医疗保健提供者和政府机构。


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/heor-service-market-29343*